Spelling suggestions: "subject:"susceptibility testing"" "subject:"usceptibility testing""
11 |
Algorithms for antibiotic susceptibility testing for pathogens causing sepsisÅhag, Stina January 2017 (has links)
This study is a part of a project at Q-linea that aims to present a rapid diagnostic instrument to speed up the process of identification of pathogens and determination of MIC-values (Minimal Inhibitory Concentration) of antibiotic needed to treat patients with sepsis. Specifically, this report is aimed to describe the development and implementation of algorithms that examine susceptibility profiles ofsepsis related pathogens where the bacteria have been exposed to different antibiotics and by different lapse of concentrations. The developed algorithms are based on a clustering technique that identify inhibited growth and present the lowest concentration needed to slow down the growth of the pathogen. The implemented solution was tested on sepsis related pathogens and the determined MIC values were compared to MIC values generated with a method commonly used in healthcare today. Approximately 90% of instances were correctly classified based on data from six hours long tests which is significantly faster than the reference method which takes 16-24 hours to complete. Furthermore, each result comes with a set of quality measures for validation of the algorithm results. Although, further studies are necessary to increase the performance at the four-hour target time, and more data is needed to validate the developed quality measures.
|
12 |
Antimicrobial Susceptibility of Clinical Oral Isolates of Actinomyces spp.Wolff, Alexandra, Rodloff, Arne C., Vielkind, Paul, Borgmann, Toralf, Stingu, Catalina-Suzana 02 June 2023 (has links)
Actinomyces species play an important role in the pathogenesis of oral diseases and infections. Susceptibility testing is not always routinely performed, and one may oversee a shift in resistance patterns. The aim of the study was to analyze the antimicrobial susceptibility of 100 well-identified clinical oral isolates of Actinomyces spp. against eight selected antimicrobial agents using the agar dilution (AD) and E-Test (ET) methods. We observed no to low resistance against penicillin, ampicillin-sulbactam, meropenem, clindamycin, linezolid and tigecycline (0–2% ET, 0% AD) but high levels of resistance to moxifloxacin (93% ET, 87% AD) and daptomycin (83% ET, 95% AD). The essential agreement of the two methods was very good for benzylpenicillin (EA 95%) and meropenem (EA 92%). The ET method was reliable for correctly categorizing susceptibility, in comparison with the reference method agar dilution, except for daptomycin (categorical agreement 87%). Penicillin is still the first-choice antibiotic for therapy of diseases caused by Actinomyces spp.
|
13 |
A COMPARISON OF TWO COMMERCIAL STRIPS WITH PREDEFINED ANTIBIOTIC CONCENTRATION GRADIENTS FOR SUSCEPTIBILITY TESTING OF PERIODONTAL BACTERIAL PATHOGENSBui, Hanh January 2013 (has links)
Objectives: Systemic antibiotics are generally recognized as providing a beneficial impact in treatment of both aggressive and chronic periodontitis. Since strains of periodontal pathogens among periodontitis patients may vary in their antibiotic drug resistance, the American Academy of Periodontology recommends antimicrobial susceptibility testing of suspected periodontal pathogens prior to administration of systemic periodontal antibiotic therapy, to reduce the risk of a treatment failure due to pathogen antibiotic resistance. E-test and MIC Test Strip assays are two in vitro antimicrobial susceptibility testing systems employing plastic- and paper-based, respectively, carriers loaded with predefined antibiotic gradients covering 15 two-fold dilutions. To date, no performance evaluations have been carried out comparing the Etest and MIC Test Strip assays in their ability to assess the in vitro antimicrobial susceptibility of periodontal bacterial pathogens. As a result, the purpose of this study was to compare the in vitro performance of E-test and MIC Test Strip assays in assessing minimal inhibitory concentration (MIC) values of four antibiotics frequently utilized in systemic periodontal antibiotic therapy against 11 fresh clinical subgingival isolates of the putative periodontal pathogen, Prevotella intermedia/ nigrescens, and to compare the distribution of P. intermedia/ nigrescens strains identified with interpretative criteria as "susceptible" and "resistant" to each of the four antibiotics using MIC values determined by the two antimicrobial susceptibility testing methods. Methods: Standardized cell suspensions, equivalent to a 2.0 McFarland turbidity standard, were prepared with 11 fresh clinical isolates of P. intermedia/nigrescens, each recovered from the subgingival microbiota of United States chronic periodontitis subjects, and plated onto to the surfaces of culture plates containing enriched Brucella blood agar. After drying, pairs of antibiotic-impregnated, quantitative, gradient diffusion strips from two manufacturers (E-test, bioMérieux, Durham, NC, USA, and MIC Test Strip, Liofilchem s.r.l., Roseto degli Abruzzi, Italy) for amoxicillin, clindamycin, metronidazole, and doxycycline were each placed apart from each other onto the inoculated enriched Brucella blood agar surfaces, so that an antibiotic test strip from each manufacturer was employed per plate against each P. intermedia/ nigrescens clinical isolate for antibiotic susceptibility testing. After 48-72 hours anaerobic jar incubation, individual MIC values for each antibiotic test strip against P. intermedia/nigrescens were read in μg/ml at the point where the edge of the bacterial inhibition ellipse intersected with the antibiotic test strip. MIC50, MIC90, and MIC range were calculated and compared for each of the test antibiotics, with essential agreement (EA) values determined per test antibiotic for the level of outcome agreement between two antimicrobial susceptibility testing methods. In addition, the identification of antibiotic "susceptible" and "resistant" strains among the P. intermedia/nigrescens clinical isolates was determined for each test antibiotic using MIC interpretative criteria from the MIC interpretative standards developed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for gram-negative anaerobic bacteria for amoxicillin, clindamycin, and metronidazole findings, and from the French Society of Microbiology breakpoint values for anaerobic disk diffusion testing for doxycycline data. Results: For amoxicillin, higher MIC50 and MIC90 values against the P. intermedia/ nigrescens strains were found with the MIC Test Strip assay than with E-test strips, resulting in a relatively low EA value of 45.5% between the two susceptibility testing methods. A higher percentage of amoxicillin "resistant" P. intermedia/nigrescens strains (72.7%) were identified by MIC Test Strips as compared to E-test strips (54.5%), although both methods found the same proportion of amoxicillin "susceptible" strains (27.3%). For clindamycin, both susceptibility testing methods provided identical MIC values (EA value = 100%), and exactly the same distributions of "susceptible" and "resistant" strains of P. intermedia/nigrescens. For metronidazole, only very poor agreement (EA value = 9.1%) was found between the two susceptibility testing methods, with MIC Test Strips exhibiting markedly higher MIC50 and MIC90 values against P. intermedia/nigrescens as compared to E-test strips. However, the distribution of "susceptible" and "resistant" P. intermedia/ nigrescens were identical between the two susceptibility testing methods. For doxycycline, relatively good agreement (EA value = 72.7%) was found in MIC concentrations between the two susceptibility testing methods, although generally lower MIC values were associated with MIC Test Strips. In addition, identical distributions of "susceptible" and "resistant" P. intermedia/nigrescens were provided by both susceptibility testing methods. Conclusions: Relative to MIC values measured against periodontal strains of P. intermedia/nigrescens, MIC Test Strips gave higher MIC values with amoxicillin and metronidazole, equal MIC values with clindamycin, and lower MIC values with doxycycline, as compared to MIC values measured with the E-test assay. Relative to the identification of antibiotic "susceptible" periodontal P. intermedia/ nigrescens strains, both susceptibility testing methods provided identical findings, suggesting that both methods appear to be interchangeable for clinical decision making in regard to identification of antibiotic-sensitive strains of periodontal P. intermedia/nigrescens. However, for epidemiologic surveillance of drug susceptibility trends, where exact MIC values are important to track over time, the relatively higher proportion of non-exact MIC differences between the two susceptibility testing methods argues against using them interchangeably. Instead, one or the other method should be used consistently for such studies. Further comparative studies of the E-test and MIC Test Strip assays are indicated using other periodontopathic bacterial species besides P. intermedia/ nigrescens, and to assess the reproducibility of MIC values provided by both in vitro susceptibility testing methods over time. / Oral Biology
|
14 |
Avaliação da resistência de Mycobacterium tuberculosis a drogas através de testes fenotípicos, moleculares comerciais e do sequenciamento genômico total / Evaluation of Mycobacterium tuberculosis resistance to drugs through phenotypic, commercial molecular tests and whole genome sequencingFeliciano, Cinara Silva 23 February 2018 (has links)
A tuberculose (TB) embora passível de tratamento efetivo, ainda é um grave problema de saúde pública em diversos países, inclusive no Brasil. Nas últimas décadas houve progressos consistentes no controle da doença, porém o avanço da resistência bacilar ainda é um desafio a ser superado, já que os mecanismos da resistência são bastante complexos e não totalmente conhecidos, o que dificulta o desenvolvimento de testes de sensibilidade com elevada acurácia. O objetivo deste trabalho foi caracterizar as mutações gênicas de cepas de Mycobacterium tuberculosis de pacientes do Brasil e de Moçambique com doença resistente a drogas através do sequenciamento genômico total, além de descrever padrões de mutações obtidos por testes moleculares comerciais e comparar estes dados com resultados de testes fenotípicos. Estudo descritivo e transversal que incluiu 30 isolados (17 do Brasil e 13 de Moçambique), submetidos aos testes moleculares comerciais Genotype MTBDRplus®, Genotype MTBDRsl®, Xpert MTB/RIF® e teste fenotípico BACTEC MGIT 960 SIRE®. Todos os isolados também foram avaliados pelo sequenciamento genômico realizado pelo Illumina MiSeq Sequencing System® e submetidos a análise de mutações que conferem resistência às drogas contra TB utilizando o TB profiler online tool. A sensibilidade e especificidade do sequenciamento genômico para detecção de resistência a rifampicina foi de 87,5% e 92,3%, respectivamente. Além disso, o sequenciamento detectou a mutação (Val170Phe) no gene rpoB em dois isolados de M. tuberculosis de Moçambique. Esta mutação não é detectada pelos testes genotípicos comerciais. A sensibilidade do sequenciamento para a isoniazida foi de 95,6% e a especificidade de 100%. Para a estreptomicina, a sensibilidade foi de 85,7% e a especificidade de 93,3%. Para o etambutol, observamos sensibilidade de 100% e especificidade de 77,2%. As mutações mais frequentes associadas à resistência à rifampicina foram a Ser450Leu e a His445Tyr no gene rpoB. Em relação à isoniazida, predominou a mutação Ser315Thr no gene katG. O sequenciamento genômico, dado seu alto poder discriminatório, tem grande potencial de fornecer informações mais acuradas sobre mecanismo gênicos da resistência bacilar, possibilitando futuramente o aprimoramento de testes diagnósticos mais precisos. / Although there is an effective treatment for tuberculosis (TB), it is still a serious public health problem in several countries, including Brazil. In the last decades, there has been consistent progress in disease control, but the increasing number of disease caused by resistant strains is still a challenge to be overcome, since the mechanisms of resistance are quite complex and not fully known, which difficult the development of susceptibility tests with high accuracy. The aim of this work was to characterize gene mutations of Mycobacterium tuberculosis strains from Brazilian and Mozambican patients with drug-resistant disease through whole genome sequencing, as well as to describe patterns of mutations obtained by commercial molecular tests and to compare these data with results of phenotypic susceptibility tests. It was a cross-sectional study that included 30 isolates (17 from Brazil and 13 from Mozambique). Commercial molecular tests Genotype MTBDRplus(TM), Genotype MTBDRsl(TM), Xpert MTB / RIF(TM) and BACTEC MGIT 960 SIRE(TM) phenotypic test were performed for all isolates. All of them were also evaluated by whole genome sequencing performed by the Illumina MiSeq Sequencing System(TM) and submitted to analysis of mutations that confer drug resistance against TB using the TB profiler online tool. The sensitivity and specificity of whole genome sequencing for detection rifampicin resistance was 87.5% and 92.3%, respectively. Also, whole genome sequencing detected the mutation (Val170Phe) in the rpoB gene in two isolates of M. tuberculosis from Mozambique. This mutation is not detected by commercial genotypic tests. The sensitivity of the whole genome sequencing for isoniazid was 95.6%, and the specificity was 100%. For streptomycin, the sensitivity was 85.7%, and the specificity was 93.3%. For ethambutol, we observed a sensitivity of 100% and specificity of 77.2%. The most frequent mutations associated with rifampicin resistance were rpoB Ser450Leu and His445Tyr. About isoniazid, the katG Ser315Thr mutation was the most frequent. Whole genome sequencing, given its high discriminatory power, has great potential to provide more accurate information about the gene mechanisms of bacilli resistance, making possible the improvement of more accurate diagnostic tests in the future.
|
15 |
Avaliação da resistência de Mycobacterium tuberculosis a drogas através de testes fenotípicos, moleculares comerciais e do sequenciamento genômico total / Evaluation of Mycobacterium tuberculosis resistance to drugs through phenotypic, commercial molecular tests and whole genome sequencingCinara Silva Feliciano 23 February 2018 (has links)
A tuberculose (TB) embora passível de tratamento efetivo, ainda é um grave problema de saúde pública em diversos países, inclusive no Brasil. Nas últimas décadas houve progressos consistentes no controle da doença, porém o avanço da resistência bacilar ainda é um desafio a ser superado, já que os mecanismos da resistência são bastante complexos e não totalmente conhecidos, o que dificulta o desenvolvimento de testes de sensibilidade com elevada acurácia. O objetivo deste trabalho foi caracterizar as mutações gênicas de cepas de Mycobacterium tuberculosis de pacientes do Brasil e de Moçambique com doença resistente a drogas através do sequenciamento genômico total, além de descrever padrões de mutações obtidos por testes moleculares comerciais e comparar estes dados com resultados de testes fenotípicos. Estudo descritivo e transversal que incluiu 30 isolados (17 do Brasil e 13 de Moçambique), submetidos aos testes moleculares comerciais Genotype MTBDRplus®, Genotype MTBDRsl®, Xpert MTB/RIF® e teste fenotípico BACTEC MGIT 960 SIRE®. Todos os isolados também foram avaliados pelo sequenciamento genômico realizado pelo Illumina MiSeq Sequencing System® e submetidos a análise de mutações que conferem resistência às drogas contra TB utilizando o TB profiler online tool. A sensibilidade e especificidade do sequenciamento genômico para detecção de resistência a rifampicina foi de 87,5% e 92,3%, respectivamente. Além disso, o sequenciamento detectou a mutação (Val170Phe) no gene rpoB em dois isolados de M. tuberculosis de Moçambique. Esta mutação não é detectada pelos testes genotípicos comerciais. A sensibilidade do sequenciamento para a isoniazida foi de 95,6% e a especificidade de 100%. Para a estreptomicina, a sensibilidade foi de 85,7% e a especificidade de 93,3%. Para o etambutol, observamos sensibilidade de 100% e especificidade de 77,2%. As mutações mais frequentes associadas à resistência à rifampicina foram a Ser450Leu e a His445Tyr no gene rpoB. Em relação à isoniazida, predominou a mutação Ser315Thr no gene katG. O sequenciamento genômico, dado seu alto poder discriminatório, tem grande potencial de fornecer informações mais acuradas sobre mecanismo gênicos da resistência bacilar, possibilitando futuramente o aprimoramento de testes diagnósticos mais precisos. / Although there is an effective treatment for tuberculosis (TB), it is still a serious public health problem in several countries, including Brazil. In the last decades, there has been consistent progress in disease control, but the increasing number of disease caused by resistant strains is still a challenge to be overcome, since the mechanisms of resistance are quite complex and not fully known, which difficult the development of susceptibility tests with high accuracy. The aim of this work was to characterize gene mutations of Mycobacterium tuberculosis strains from Brazilian and Mozambican patients with drug-resistant disease through whole genome sequencing, as well as to describe patterns of mutations obtained by commercial molecular tests and to compare these data with results of phenotypic susceptibility tests. It was a cross-sectional study that included 30 isolates (17 from Brazil and 13 from Mozambique). Commercial molecular tests Genotype MTBDRplus(TM), Genotype MTBDRsl(TM), Xpert MTB / RIF(TM) and BACTEC MGIT 960 SIRE(TM) phenotypic test were performed for all isolates. All of them were also evaluated by whole genome sequencing performed by the Illumina MiSeq Sequencing System(TM) and submitted to analysis of mutations that confer drug resistance against TB using the TB profiler online tool. The sensitivity and specificity of whole genome sequencing for detection rifampicin resistance was 87.5% and 92.3%, respectively. Also, whole genome sequencing detected the mutation (Val170Phe) in the rpoB gene in two isolates of M. tuberculosis from Mozambique. This mutation is not detected by commercial genotypic tests. The sensitivity of the whole genome sequencing for isoniazid was 95.6%, and the specificity was 100%. For streptomycin, the sensitivity was 85.7%, and the specificity was 93.3%. For ethambutol, we observed a sensitivity of 100% and specificity of 77.2%. The most frequent mutations associated with rifampicin resistance were rpoB Ser450Leu and His445Tyr. About isoniazid, the katG Ser315Thr mutation was the most frequent. Whole genome sequencing, given its high discriminatory power, has great potential to provide more accurate information about the gene mechanisms of bacilli resistance, making possible the improvement of more accurate diagnostic tests in the future.
|
16 |
Développement de nouvelles méthodes moléculaires pour le typage et l’étude de la sensibilité aux antibiotiques de C. trachomatis / Development of new molecular methods for typing and study of antibiotic susceptibility of Chlamydia trachomatisPeuchant, Olivia 17 November 2011 (has links)
Chlamydia trachomatis est une bactérie à développement intracellulaire obligatoire, divisée en 19 sérovars parmi lesquels les sérovars D-K sont responsables d’infections oculo-génitales et les sérovars L de la lymphogranulomatose vénérienne (LGV). En France, C. trachomatis est le principal agent bactérien responsable d’infections sexuellement transmissibles (IST). Les méthodes moléculaires occupent une place de choix dans le dépistage et l’épidémiologie des infections à C. trachomatis. Grâce à leur utilisation à partir de prélèvements non invasifs, nous disposons de chiffres de prévalence qui s’élèvent à 1,5% dans la population générale, 3,6% chez les femmes âgées de 18 à 24 ans sexuellement actives et 10 à 15% dans les centres à vocation de dépistage des IST. N’ayant aucune donnée chez la femme enceinte, le programme hospitalier de recherche clinique (MATIST) que nous avons mis en place chez les femmes enceintes suivies au CHU de Bordeaux a montré une prévalence de l’infection à C. trachomatis de 2,5%, à M. genitalium de 0,8% et à N. gonorrhoeae de 0%. Chez les femmes de moins de 24 ans, la prévalence était respectivement de 7,9% et 2,4%. La compréhension de l’épidémiologie et de la dissémination des infections à C. trachomatis nécessite la mise au point de techniques de typage performantes d’autant qu’un seul sérovar, le sérovar E, est rencontré dans près de la moitié des cas. Nous avons développé une méthode de typage moléculaire, la MLVA (MultiLocus Variable Number of Tandem Repeat Analysis), qui analyse le polymorphisme associé aux répétitions en tandem et permet un typage intra-sérovar. Cinq VNTRs ont été identifiés. La méthode a été automatisée puis appliquée à 220 souches et échantillons cliniques de C. trachomatis de génovar E, permettant d’identifier 25 types MLVA. Les souches d’origine ano-rectale isolées de patients homosexuels et les souches suédoises appartenant au nouveau variant ont été individualisées au sein de deux types MLVA uniques et distincts, suggérant une origine clonale. L’ensemble des résultats obtenus ont montré que la MLVA est un outil de typage moléculaire performant, plus discriminant que les autres méthodes auxquelles nous l’avons comparée. De plus, dans le cadre de la surveillance épidémiologique de la LGV ano-rectale due au variant L2b qui sévit en Europe depuis 2003 presque exclusivement chez les homosexuels, nous avons identifié le premier cas de LGV ano-rectale chez une femme. Enfin, nous avons développé une technique de PCR en temps réel permettant une détermination objective de la concentration minimale inhibitrice d’un antibiotique donné vis-vis de C. trachomatis. Cette technique a également montré que les antibiotiques étudiés n’avaient qu’une activité bactériostatique sur C. trachomatis. / Chlamydia trachomatis is an obligate intracellular bacterium, divided into 19 serovars, among which serovars D-K are responsible for oculo-genital infections and serovars L of lymphogranuloma venereum (LGV). In France, C. trachomatis is the main bacterial cause of sexually transmitted diseases (STI). Molecular methods are the methods of choice for the C. trachomatis detection and epidemiology. Through their use, it has been shown that the prevalence of C. trachomatis infection rise up to 1.5% in the general population, to 3.6% for sexually experienced women aged 18-24 and to 10-15% in STI medical settings. As no data were available for pregnant women, we conducted a clinical research study (MATIST) in pregnant women at the Bordeaux University hospital. The prevalence of C. trachomatis, M. genitalium and N. gonorrhoeae infections was 2.5%, 0.8% and 0%, respectively. In women under 24 years, the prevalence of C. trachomatis, and M. genitalium infections was 7.9% and 2.4%, respectively. Understanding the epidemiology and the spread of C. trachomatis infection requires the development of efficient typing techniques knowing that a single serovar, serovar E, is found in nearly half the cases. We developed a MLVA (MultiLocus Variable-Number of Tandem Repeat Analysis) method which analyzes the genome polymorphism associated to tandem repeats and allowed intra-serovar subtyping. Five VNTRs were identified. The automated method was applied on 220 C. trachomatis genovar E clinical specimens and isolates, yielding 25 MLVA types. All anorectal isolates from men who have sex with men exhibited the same MLVA type, suggesting clonal spread. In the same way, we confirmed the clonal origin of the Swedish new variant of C. trachomatis. MLVA appears to be a good tool for molecular typing, with a higher discriminatory power than those of other methods used for comparison. Since 2003, a LGV proctitis outbreak caused by the new variant L2b has been reported in Europe in men who have had sex with HIV-positive men. We reported the first case of C. trachomatis L2b proctitis diagnosed in a woman. Finally, we developed a real-time PCR method allowing an objective determination of minimum inhibitory concentration of antibiotics for C. trachomatis. Our results also showed that all antibiotics studied only had bacteriostatic activity on C. trachomatis.
|
17 |
Direktresistensbestämning för blododlingar : Volymoptimering och reproducerbarhet / Direct antimicrobial susceptibility testing on blood cultures : Volume optimization and reproducibilityWestman, Natalee January 2021 (has links)
Direct antimicrobial susceptibility testing (dAST) is not a standardized method and there is no recommendations regarding the volume of blood culture media to be used. The aim of the study was to optimize the method of dAST by determining a volume of blood culture media in µL to be used and to test the reproducibility of the volume optimized method. The dASTs (n=160) were performed on blood culture bottles (n=40) inoculated with reference bacteria (n=4), using four test volumes (50 µL, 75 µL, 100 µL and 125 µL). The optimized method was implemented on frozen and fresh bacterial isolates (n=120) derived from blood cultures. Susceptibility tests according to EUCASTs method for disk diffusion was also performed. Deviations in SIR-categorical agreement was calculated. The optimal volume of blood culture media for dAST was 75 µL. All dASTs were approved for three out of four reference bacteria whereas for the fourth reference bacteria eight out of ten dASTs was approved. Testing the reproducibility, the optimized method showed a sensitivity and specificity of 100 %. No deviation in categorical agreement of SIR-categorization was observed. The result shows a possibility of implementing a standardized method for dAST regarding the volume of blood culture media. / Vid direktresistensbestämning används blododlingsmedium för tillverkning av bakteriesuspensioner. Metoden är inte standardiserad och det finns ingen rekommenderad volym blododlingsmedium som bör användas. Syftet med studien var att optimera metoden för direktresistensbestämning genom att bestämma en volym blododlingsmedium i µL som används för tillverkning av bakteriesuspensioner. Den optimerade metodens prestanda utvärderades därefter på kliniska patientisolat. Metoden optimerades genom att direktresistensbestämningar (n=160) utfördes baserat på fyra volymer (50 µL, 75 µL, 100 µL och 125 µL) blododlingsmedium (n=40), som var inokulerade med fyra olika referensstammar. Den optimerade metodens reproducerbarhet testades på frysta och färska patientisolat (n=120) genom jämförelse av SIR-kategorisering mellan direktresistensbestämning samt resistensbestämning enligt EUCASTs metod för diskdiffusion. Den optimala volymen blododlingsmedium med kända referensstammar fastställdes vara 75 µL då samtliga direktresistensbestämningar godkändes för tre av fyra referensstammar, för den fjärde referensstammen godkändes åtta av tio. Då metoden implementerades på kliniska patientisolat från positiva blododlingar var känsligheten och specificiteten 100 % avseende kategorisk överensstämmelse enligt SIR-systemet. Inga avvikelser avseende SIR-kategorisering observerades. Resultaten visar att det är möjligt att optimera metoden avseende volymen blododlingsmedium som används för direktresistensbestämning på blododlingsflaskor. Då den optimerade metodens känslighet och specificitet var 100 %, är det möjligt att implementera metoden i rutinarbetet.
|
18 |
Re-Evaluierung, methodische Optimierung und weitergehende Charakterisierung der Empfindlichkeitstestung von Mycobacterium tuberculosis mit dem BacT/Alert 3D (bioMérieux)Knigge, Anna Sophie 12 March 2014 (has links)
Es erfolgte die Re-Evaluierung der Empfindlichkeitstestung von Tuberkuloseerregern mit dem BacT/Alert-3D-System (bioMérieux) unter besonderer Berücksichtigung des Materialwechsels der Kulturflasche von Glas auf Plastik. Dazu wurden insgesamt 61 vergleichende MHK-Bestimmungen mit diesen beiden Flaschentypen durchgeführt, wobei sechs Antituberkulotika (INH, RMP, EMB, SM, PTH und MOX) sowie zwölf Mykobakterienstämme (davon neun Mtb.) untersucht wurden. Dabei findet sich kein Unterschied in den MHK-Werten zwischen Glas- und Plastikflaschen. Die Plastikflaschen sind folglich ebenso wie die Glasflaschen zur Empfindlichkeitstestung von Tuberkuloseerregern mit dem BacT/Alert-3D-System geeignet. Bei der bisherigen Methode wurde bei der PZA-Testung auf die Verwendung der Kontrollflasche zur Festlegung der Untersuchungszeit verzichtet, weil der erniedrigte pH-Wert ein unverhältnismäßig langsames oder gar fehlendes Wachstum in dieser Flasche bewirkt. Durch Optimierung von pH-Wert (pH 5,9) und PZA-Testkonzentration (200 mg/l) wurde erreicht, dass die PZA-Testung nach der gleichen Methode wie auch bei den anderen Antituberkulotika praktiziert, durchgeführt werden kann. Im weiteren wurde untersucht, wie hoch der Anteil resistenter Mutanten in Mischkulturen sein muss, um erkannt zu werden. Dazu wurden dem sensiblen Stamm H37Rv jeweils isogene Mutanten mit Monoresistenzen gegen INH, RMP oder SM bzw. EMB- und PZA-resistente Stämme in verschiedenen Anteilen zugesetzt. Es zeigte sich, dass ein Anteil von 1% resistenter Stämme noch nicht sicher detektiert wird. / The purpose of this paper is to optimize and reevaluate the methods of susceptibility testing of M.tuberculosis with the BacT/Alert 3D System (bioMérieux). The key aspect was the comparison between culture bottles from glass between those made out of plastic material. Therefore 61 comparative MIC-tests were carried out, with six antituberculous drugs (INH, RMP; EMB, SM, PTH and MOX) and twelve mycobacterial strains (nine Mtb.) in order to compare the MIC in the two different bottle types. The MIC of 40 comparative tests between plastic culture bottles were identical to those in glass material. Only 18 test results deviated between the two bottle types. In each of those tests the discrepancy was only one degree of dilution, which is considered as not relevant. Resistant strains were found in three tests, with no difference between glass and plastic bottles. The deviant twelve results of Mtb. strains show a six times higher MIC-value in plastic bottles and a six times lower MIC in plastic bottles. In the case of the substance INH all four discrepant results had a higher MIC in the plastic bottle. Since these results were known by the Institut für Medizinische Mikrobiologie und Infektionsepidemiologie of the University Leipzig, it was consequently used with good results in the laboratory routine, as well as in external quality control (INSTAND-Ringversuche 2009 to 2011).
The second topic of this study was to optimize the current method of susceptibility testing of Mtb. concerning pyrazinamide (PZA). In the current method the low pH of the dilution (5.5) with the resulting weak growth of the strains forced the laboratory assistant to abandon the 1% control bottle as endpoint of measurement. The new and optimized pH of 5.9 and a concentration of PZA of 200 mg/l allows the susceptibility testing of PZA with the same method as practiced for the other antituberculous drugs.
Yet another focus of this study was the sensitivity of the BacT/Alert 3D System to detect heteroresistant clones in the mycobacterial broth. Resistant clones and fully susceptible Mtb. strain (H37Rv) were mixed in different percentages and susceptibility testing was performed. It could be shown, that a secure detection of resistant clones is not possible at a percentage 1% of resistant clones in the culture.
|
19 |
Resistensbestämning av bakterier : Studie av odlingsbuljongens påverkan på resultatet i tidigare rapporterad forskning samt genom experimentell undersökning. / Determination of bacterial resistance : Study of the influence of broth on the results in previously reported reserch and through experimental investigation.Svensson, Åsa January 2023 (has links)
Ökande antibiotikaresistens utgör en allvarlig samhällsutmaning. För resistensbestämning av bakterier används standardmetoden buljongspädning. Då bestäms minsta inhiberande koncentration (MIC) som den lägsta koncentration av antibiotika som kan förhindra tillväxt. Examensarbetets syfte var att undersöka om val av odlingsbuljong påverkar MIC-värdet för Gramnegativa bakterier. En litteraturundersökning genomfördes av studier som jämfört resistensbestämning i standardbuljong med alternativ buljong. Därutöver gjordes en experimentell jämförelse. Litteraturstudien visade att buljongens sammansättning kan ha betydelse för MIC-värdet, men resultatet varierade med både bakteriearter och typer av antibiotika. Viktigt att beakta är det begränsade materialet i studien, möjliga förklaringar till MIC-varianser är exempelvis bikarbonat och antibiotikums olika känslighet för ämnet. Den experimentella studien visade att buljongvalet inte hade någon inverkan på MIC-värdet när det undersöktes för Klebsiella pneumoniae och antibiotikan meropenem. Det kan möjligen förklaras av att effekten av meropenem inte påverkas av buljongvalet. Slutsatsen är att många faktorer påverkar MIC-värdet och att standardbuljongen är en tillgång med stor mängd historiska data som kan nyttjas för att följa resistensutvecklingen, även om alternativa buljonger i vissa fall kan vara bättre lämpade för att förutsäga behanlingsbarheten. Buljongval bör väljas med noggrannhet efter rådande omständigheter. / Increasing antibiotic resistance is a concerning societal challenge. The standard test for measuring antibiotic susceptibility of bacteria is the method of broth microdilution. This method is used to determine the minimum inbibitory concentration (MIC), defined as the lowest concentration of an antibiotic that can inhibit the growth of a specific strain of a bacterium. This study aimed to investigate whether the choice of broth affects the MIC-value for Gram-negative bacteria. A literature review was conducted to examine studies comparing standard broth against alternative broth, alongside an experimental comparison of the same. The result of the literature review indicated that the composition of the broth does have an effect. However, the effect varies depending on the bacterial species and type of the antibiotic that was analyzed. Its important to note the limited amount of data from both prior work and this study, but one possible explanation to the variance in MIC-values could be e.g., bicarbonate and the specific antibiotic´s sensitivity to this substance. The experimental part of this study concluded that the choice of broth did not affect the resulting MIC-value when the antibiotic susceptibility of Klebsiella pneumoniae to meropenem was analyzed. This could be attributed to the efficacy of meropenem being unaffected by the broths used in this study. The conclusing of this study is that multiple factors contribute to the resulting MIC-value, and that the standard broth with its large volume of historical data, is a valuable asset to use when tracking the evolution of antibiotic resistance, even though an alternative broth may be better suited to predict treatability. The choice of broth should be made with great care and be adapted to actual circumstances and conditions.
|
20 |
EUCAST rapid antimicrobial susceptibility testing (RAST) : Utvärdering av 16-20h RAST och dess fördelar vid implementering i klinisk diagnostik. / EUCAST rapid antimicrobial susceptibility testing (RAST) : Evaluation of 16-20h RAST and Its Benefits in Clinical Diagnostic ImplementationHörnell, Simon January 2024 (has links)
Bacterial bloodstream infections represent a severe and potentially life-threatening condition. Diagnostic tools, providing rapid species identification and antimicrobial susceptibility testing have a great impact on disease progression and treatment optimization. Typically, antimicrobial susceptibility testing involves a time-consuming process, and faster methods are likely to contribute in clinical settings. This study aimed to assess the reliability of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) rapid antimicrobial susceptibility testing (RAST) with a 16-20-hour incubation period for implementation in a clinical microbiology laboratory. This method was conducted alongside the standardized disk diffusion method from EUCAST, encompassing all bacterial species compatible with 16-20-hour RAST. The method was executed 80 times, and over 450 readings were performed. It confirms EUCAST's method validation, affirming 16-20-hour RAST as a swift and precise method for blood bacterial resistance determination. All inhibition zones were readable, with 89% of antibiotics tested falling within 1 mm of the set target value. Notable deficiencies were observed in antibiotic-species combinations, such as trimethoprim/sulfamethoxazole and gentamicin against E. coli, and erythromycin against S. pneumoniae. Accurate interpretation of inhibition zones demands precise reading practices as some zones were ambiguous. The study also underscores the importance of overnight cultures in antimicrobial susceptibility testing via standardized disk diffusion, accentuating 16-20-hour RAST's pivotal role in potentially accelerating resistance determination by up to a day. Given its commendable performance, 16-20-hour RAST is ready to be incorporated into the standard procedures at clinical microbiology laboratories, as demonstrated by its successful adoption at Unilabs, Skövde.
|
Page generated in 0.1251 seconds